AtriCure, Inc.

ATRC ·Healthcare, Medical Devices, United States

Net Cash Flow Breakdown

FY2025 FY2024 FY2023 FY2009

Total Cash from Operations: $59.3M

Line Item	Value	% of Total
Capital Expenditures	$9.1M	15.3%
Other Investing	$5.5M	9.3%
Net Cash Flow	$44.7M	75.4%